• Contact us
  • Investor Login
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
    • Thought leadership
    • SFDR disclosures
  • Team
  • Media
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
    • Thought leadership
    • SFDR disclosures
  • Team
  • Media
  • Contact us
  • Investor Login
  • All
    media
  • PAI publications
  • Press releases
  • Videos
  • 21 Jul 2017

    CVC Fund III and PAI Europe VI to reinvest in Grupo Cortefiel

    Grupo Cortefiel operates over 2,000 points of sale in 90 countries with three main brands. Cortefiel, aimed at men and women over 40, Springfield, aimed at 30-40 year old men and women and Women’s Secret, Iberia’s largest specialised lingerie chain.  
    Read more 2579
  • 21 Jul 2017

    CVC Fund III and PAI Europe VI to reinvest in Grupo Cortefiel

    Grupo Cortefiel operates over 2,000 points of sale in 90 countries with three main brands. Cortefiel, aimed at men and women over 40, Springfield, aimed at 30-40 year old men and women and Women’s Secret, Iberia’s largest specialised lingerie chain.  
    Read more 2579
  • 17 Jul 2017

    PAI Partners to exit ADB Safegate, a global Airport Performance Solutions provider

    When we acquired ADB in 2013, it was a leading player in airfield ground lighting. Four years later, through organic initiatives and the transformational combination with Safegate, the group has become the global leader in airfield guidance systems, providing airports worldwide with unique end-to-end airfield management solutions.
    Read more 2576
  • 08 Jun 2017

    PAI Partners enters into exclusive negotiations for the sale of a majority stake in DomusVi

    Under PAI’s ownership, the company has transformed from a French nursing home operator into a European leader across all areas of elderly care.  
    Read more 2570
  • 15 May 2017

    Advent International and PAI Partners enter into exclusive negotiations for the acquisition of IPH

    The proposed transaction would create a leading European distributor of industrial supplies through the combination of Brammer and IPH.  
    Read more 2565
  • 11 May 2017

    PAI Partners enters into exclusive negotiations for the acquisition of ELITech

    ELITech Group is a manufacturer of specialty in-vitro diagnostics equipment and reagents.  
    Read more 2560
  • 22 Jan 2017

    PAI Partners enters exclusive negotiations with Partners Group and PSP Investments for the sale of Cerba HealthCare

    Under PAI Partners' ownership the business has expanded to become a European leader in clinical pathology.
    Read more 2545
  • 19 Jan 2017

    Ethypharm acquires Martindale Pharma in the UK

    Martindale Pharma is a leading UK-based specialty pharmaceutical company providing essential medicines to over 50 countries around the world. The company specializes in the field of opioid addiction, emergency care and sterile injectables.
    Read more 2541
  • 01 Dec 2016

    PAI Partners and Goldman Sachs agree sale of the Xella Group to Lone Star

    Read more 1590
  • 11 Aug 2016

    Roompot Vakanties to be sold to PAI Partners

    The acquisition will enable Roompot to further grow its position as the largest provider of quality recreational accommodations in the Netherlands and accelerate the implementation of its development plan.
    Read more 2075
  • 09 Jun 2016

    PAI Partners has signed an agreement to acquire Ethypharm

    Ethypharm is a leading European specialty pharma focusing on growing end-markets such as the treatment of pain and addictions. With a presence in France, Germany, the UK, Canada, the US and China, Ethypharm generates over €200 million in sales.
    Read more 385
1‒7891011‒13

Press enquiries

PAI Partners
Dania Saidam
+44 20 7297 4678
Greenbrook (UK)
Peter Hewer
Demi Kurban
+44 20 7952 2000
[email protected]
ICR (US)
Brian Ruby
Chris Gillick
+1 646 277 1298
[email protected]
H/Advisors Havas Paris (FR)
Sarah Duparc
+33 6 46 72 39 99
Estelle Bleuze
+33 6 73 97 94 17
[email protected]

Follow us

Follow us on social media for regular updates and to join the conversation
Back to top
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
    • Business Services
    • Food & Consumer
    • Industrial Goods & Services
    • Healthcare
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
  • Team
    • Client & Capital Group
    • Communications Team
    • Compliance Team
    • Country Teams
    • ESG Team
    • Finance Team
    • HR Team
    • Investment Group
    • CCG
    • IT Team
    • Mid-Market Fund Team
    • PAI Performance Group
    • Sector Teams
  • Media
    • PAI publications
    • Press releases
    • Videos
© PAI 2025. | PAI Partners 2019 | PAI SAS: Registered in France No. 904 479 649, PAI SAS is a fund management company approved and regulated by the AMF in France (approval number GP-20240001). PAI Partners S.à r.l. : Registered in Luxembourg No. B136689. PAI Partners S.à r.l. is a fund management company approved and regulated by the CSSF in Luxembourg (approval number N. A00000625). PAI Partners (UK) Limited: Registered in the United Kingdom No 04015677. PAI Partners (UK) Limited is a financial advisory company approved and regulated by the FCA in the United Kingdom (approval number 984663). PAI and PAI Partners are registered trademarks.   
  • Investor Login
  • Contact us
  • Terms & Conditions
  • Legal disclaimer
  • Cookie Policy
  • Accessibility
  • Privacy notice
  • Whistleblowing Policy